Stock Events

Stock Events

Actinium Pharmaceuticals (ATNM) Q2 2025 Earnings

9MayConfirmed

Q2 2024

Q3 2024

Q4 2024

Q2 2025

-0.51

-0.44

-0.38

-0.31

Details

Expected EPS

-0.428

Actual EPS

-0.51

Surprise EPS

-0.08

Surprise Percent

+19.16%

Description

Actinium Pharmaceuticals (ATNM) has reported earnings of -0.51 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.